REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTclarke Regulatory News (CTO)

Share Price Information for Tclarke (CTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 164.00
Bid: 162.00
Ask: 164.00
Change: 0.75 (0.46%)
Spread: 2.00 (1.235%)
Open: 164.00
High: 164.00
Low: 164.00
Prev. Close: 163.25
CTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Trading Update

10 May 2023 07:00

RNS Number : 8475Y
TClarke PLC
10 May 2023
 

TClarke plc

 

AGM AND TRADING UPDATE

 

Strong Trading Continues In Line With Market Expectations

 

Increased Revenue Visibility Outside of London

 

Ahead of the 111th Annual General Meeting, being held today at 10.00am at 30 Crown Place, Earl Street, London EC2A 4ES, TClarke plc ("TClarke", the "Group" or the "Company"), the Building Services Group, issues a Trading Update covering the period from 1 January 2023 to date.

 

The Group is pleased to report that trading in the early months of 2023 has continued to be strong. The Board remains highly condent that the Group will successfully deliver its growth strategy so that our revenues will exceed £500m for the first time in the current year.

 

Our forward order book has been replenished and so far during 2023 it has been strengthened significantly. The forward order book now stands at £720m (2022: £585m) and TClarke is well-positioned to manage additional revenues in our various market sectors.

 

The Group has proactively invested in resources and capacity to support its growth ambitions, resulting in TClarke being well prepared for potential future opportunities and challenges.

 

An important message when compared to previous years, is the increased visibility of our revenues outside of London, through the growth of our work in the healthcare sector and larger projects. Our infrastructure sector order book for example, which includes projects in Healthcare, has increased by £65m since the start of 2023.

 

Whilst maintaining our strict selective approach to tendering, the Board is encouraged by the strength of our position in the market and it expects the Group's growth to continue into 2024.

 

Overall, the outlook for TClarke continues to be very positive and we look forward to reporting on the progress that we make over the remainder of the year.

 

Mark Lawrence, CEO, commented:

 

"The Group's continued confidence in delivering a strong full-year performance in line with the market expectations is reassuring and is an indication of the Company's clear understanding of its capabilities and of its ability to manage its resources effectively.

 

TClarke has a strong management team, a clear strategic vision, and a solid operational structure, which positions us well for future success".

 

The next update is scheduled for 13 July 2023 with the release of the Group's Half Year results for the six months ending 30 June 2023.

 

-ends-

 

 

10 May 2023

 

For further information contact:

 

TClarke plc

Mark Lawrence, Group Chief Executive

Trevor Mitchell, Finance Director

Tel: 020 7997 7400

http://www.tclarke.co.uk

Cenkos Securities plc (Corporate Broker)

Ben Jeynes (Corporate Finance)

Alex Pollen (Sales)

Tel: 020 7397 8900

http://www.cenkos.com

 

RMS Partners

Simon Courtenay

Tel: 020 3735 6551

http://www.rmspartners.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAKSNEFEDEFA
Date   Source Headline
12th Apr 202311:15 amRNSNotice of AGM
27th Mar 202310:26 amRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSTClarke - Preliminary Results
31st Jan 20237:00 amRNSNotice of Investor Presentation
26th Jan 20237:00 amRNSTrading Statement
4th Jan 202312:09 pmRNSBlock listing Interim Review
24th Nov 20227:00 amRNSTrading Statement
1st Nov 20225:13 pmRNSESOT Share Purchase
25th Oct 20222:14 pmRNSESOT Share Purchase
18th Jul 20227:00 amRNSInvestor Presentation
14th Jul 20227:00 amRNSHalf-year Report
5th Jul 202212:12 pmRNSBlock listing 6 Monthly Return
29th Jun 20227:00 amRNSNotice of Investor Presentation
23rd Jun 202210:45 amRNSNotice of Results
22nd Jun 20222:46 pmRNSChange of Auditor
22nd Jun 20229:37 amRNSTotal Voting Rights
17th May 20227:00 amRNSTClarke to Present at Mello Investor Conference
11th May 202210:27 amRNSResult of AGM
11th May 20227:00 amRNSAGM Statement
10th May 202212:51 pmRNSESOT Share Purchase
5th May 20223:52 pmRNSESOT Share Purchase
3rd May 20229:03 amRNSDirector/PDMR Shareholding
26th Apr 20224:29 pmRNSVesting of EIP share awards April 2022
20th Apr 20229:27 amRNSChange of Registered Office
8th Apr 202210:09 amRNSPublication of Annual Report and Notice of AGM
8th Apr 20227:00 amRNSDirectorate Change
16th Mar 20228:27 amRNSDirector/PDMR Shareholding
16th Mar 20228:21 amRNSTotal Voting Rights
11th Mar 20227:00 amRNSInvestor Presentation
9th Mar 20227:02 amRNSDirectorate Change
9th Mar 20227:00 amRNSNotification of Investor Presentation
9th Mar 20227:00 amRNSFinal Results
2nd Feb 20223:21 pmRNSTotal Voting Rights
1st Feb 20227:00 amRNSNotification of Investor Presentation
27th Jan 20227:00 amRNSTrading Statement
4th Jan 202211:28 amRNSBlock listing Interim Review
9th Dec 20211:11 pmRNSESOT Share Purchase
6th Dec 20219:40 amRNSESOT Share Purchase
3rd Dec 202111:51 amRNSTR-1: Notification of Change of Holding
1st Dec 20213:02 pmRNSPDMR Disclosure
1st Dec 20213:00 pmRNSTotal Voting Rights and Share Capital
25th Nov 20217:00 amRNSTrading Statement
18th Oct 20217:00 amRNSInvestor Presentation
6th Oct 202111:14 amRNSPDMR Holding
6th Oct 202111:10 amRNSBlock Listing Application
22nd Sep 20217:00 amRNSNotice of Investor Presentation
17th Aug 20211:41 pmRNSDirector/PDMR Shareholding
9th Aug 20217:00 amRNSTClarke Selected for NHS Smart Buildings Framework
20th Jul 20217:00 amRNSHalf-year Report
5th Jul 20217:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.